middle.news
EMVision Adds $4.3m Funding as Brain Scanner Programs Progress
8:45am on Monday 28th of September, 2026 AEST
•
Medical Devices
Read Story
EMVision Adds $4.3m Funding as Brain Scanner Programs Progress
8:45am on Monday 28th of September, 2026 AEST
Key Points
$4.3 million R&D tax refund received for FY2026 activities
Non-dilutive funding supports clinical, engineering and product development
emu™ pivotal trial spans leading US and Australian stroke centres
First Responder program completes aeromedical and in-field feasibility work
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE